2424-58-0

Usage

Uses

Used in Polymer and Resin Synthesis:
Allyl hydrogen maleate is used as a monomer for the production of various thermosetting plastics, adhesives, and coatings. Its reactivity and ability to cross-link with other molecules make it a valuable component in these applications.
Used in Automotive Coatings and Composites:
In the automotive industry, allyl hydrogen maleate is used as a cross-linking agent to enhance the durability and performance of coatings and composites. Its inclusion in these products contributes to improved resistance to wear, weathering, and other environmental factors.
Safety Precautions:
It is important to handle allyl hydrogen maleate with care, as it can be a skin and eye irritant. Additionally, it has the potential to form explosive peroxides when exposed to air, so proper storage and handling procedures must be followed to ensure safety.

InChI:InChI=1/C7H8O4/c1-2-5-11-7(10)4-3-6(8)9/h2-4H,1,5H2,(H,8,9)/b4-3-

Upstream product

• 108-31-6 maleic anhydride 
• 107-18-6 allyl alcohol 

Downstream Products

• 937735-06-3 C₄₀H₄₂Cl₂N₄O₅ 
• 937735-08-5 C₃₉H₃₉Cl₂FN₄O₄ 
• 937735-07-4 C₃₉H₃₉Cl₃N₄O₄ 
• 937735-09-6 C₃₉H₃₉Cl₂FN₄O₄ 
• 937735-01-8 C₃₄H₃₆Cl₂N₄O₄ 
• 937735-10-9 C₃₅H₄₀Cl₂N₄O₄ 
• 937735-02-9 C₃₅H₃₉Cl₂N₅O₅ 
• 937735-03-0 C₃₆H₄₀Cl₂N₄O₅ 

Relevant academic research and scientific papers

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

The invention relates to a compound of Formula I, pharmaceutical compositions comprising a compound of Formula I, and pharmaceutically acceptable slats thereof, pharmaceutical compositions comprising such compounds and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I to a subject in need thereof.

APAF-1 INHIBITOR COMPOUNDS

Derivatives of 2,5-piperazinedione of formula (I) are apoptotic peptidase activating factor 1 (Apaf-1) inhibitors, therefore they are useful as active pharmaceutical ingredients for the prophylaxis and/or treatment of a pathological and/or physiological condition associated with an increase of apoptosis.

COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES

The invention relates to a compound (I) wherein R is a heterocyclyl radical; R1 and R2 are independently H or alkyl; R3 is H, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl; R4 and R5 are independently H or alkyl; q is a number selected from 0 and 1; and the salts, solvates, prodrugs or stereoisomers thereof having inhibitory activity for UBC13-UEV interactions and which can be used in the production of pharmaceutical compositions intended for antitumor therapy or the treatment and/or prophylaxis of diseases associated to metabolic pathways involving the UBC13 enzyme, metabolic pathways involving transcriptional factor NF-κB, or pathways involving PCNA or RAD6. ????????R- (CR1R2) q-CO-N (R3)-C(R4R5)-CO-NH2?????(I)